HylatopicPlus description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

HylatopicPlus

Onset Dermatologics LLC

Hylatopic Plus CreamNON-COMEDOGENIC PARABEN FREE


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

INDICATIONS FOR USE

Under the supervision of a healthcare professional, HylatopicPlus® Cream is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis. HylatopicPlus® Cream also helps to relieve dry, waxy skin by maintaining a moist wound & skin environment, which is beneficial to the healing process.

HYLATOPICPLUS CONTRAINDICATIONS

HylatopicPlus® Cream is contraindicated in persons with a known hypersensitivity to any of the components of the formulation.

WARNINGS

Use only as directed. Keep out of the reach of children. Avoid contact with eyes. For topical use only. Not for ophthalmic use. Do not apply within four hours prior to a radiation session.

PRECAUTIONS AND OBSERVATIONS

  • HylatopicPlus® Cream does not contain a sunscreen and should not be used prior to extended exposure to the sun.
  • If clinical signs of infection are present, appropriate treatment should be initiated; use of HylatopicPlus® Cream may be continued during the anti-infective therapy.
  • If the condition does not improve within 10-14 days, consult a physician.
  • HylatopicPlus® Cream may dissolve fuchsin when this dye is used to define the margins of the radiation fields to be treated.

INSTRUCTIONS FOR USE

Dispense HylatopicPlus® Cream into palm of hand and apply to affected area 3 times per day, or as directed by a physician.Massage gently into the skin until completely absorbed. If the skin is broken, cover with appropriate dressing.

INGREDIENTS

Water, Glycerin, Ethylhexyl Palmitate, Cetearyl Alcohol, Propylene Glycol, Dicetyl Phosphate, Petrolatum, Theobroma Grandiflorum Seed Butter, Dimethicone, Ceteareth-10 Phosphate, Steareth-10, Phenoxyethanol, Hydroxypropyl Bispalmitamide MEA (Ceramide), Tocopheryl Acetate, Sodium Hyaluronate, Disodium EDTA and Sodium Hydroxide.

HOW SUPPLIED

HylatopicPlus® Cream is available in 3g professional sample tubes (NDC 16781-216-04),100g commercial tubes (NDC 16781-216-96) and 450g commercial jars (NDC 16781-216-16).

Caution: Federal law restricts this device to sale by or on the order of a physician or other licensed health care practitioner.

Store between 59°F - 86°F (15°C - 30°C).

Manufactured for:
Onset Dermatologics
Cumberland, RI 02864
(888) 713-8154
www.onsetdermatologics.com

HylatopicPlus 

Rx Only
For Topical
Dermatological and
External Use Only

HylatopicPlus 

Symptom relief for atopic dermatitis, allergic contact dermatitis, and radiation dermatitis

P/N 2623 Rev. 4

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 450 Gram Jar Carton

NDC 16781-216-16

Rx Only

HylatopicPlus Cream 

Symptom Relief for Atopic Dermatitis,

Allergic Contact Dermatitis and Radiation Dermatitis

Net Weight 450g (15.9 oz) 

 

HylatopicPlus

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 100 Gram Tube Carton

NDC 16781-216-96

HylatopicPlus Cream

Rx Only

Net Weight 100g

HylatopicPlus

 

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 3 Gram Carton

NDC 16781-216-04

HylatopicPlus

Cream

Rx Only Device

Professional Sample

Not for Sale

Net Weight 3g

HylatopicPlus

HylatopicPlus

CREAM

Product Information

Product Type Prescription medical device label Item Code (Source) NDC:16781-216
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
water
GLYCERIN
ETHYLHEXYL PALMITATE
propylene glycol Propylene Glycol
petrolatum
DIMETHICONE
STEARETH-10
ALPHA-TOCOPHEROL ACETATE ALPHA-TOCOPHEROL
PHENOXYETHANOL
SODIUM HYDROXIDE
CETOSTEARYL ALCOHOL
DIHEXADECYL PHOSPHATE
EDETATE DISODIUM
THEOBROMA GRANDIFLORUM SEED BUTTER
HYALURONATE SODIUM
HYDROXYPROPYL BISPALMITAMIDE MONOETHANOLAMIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 450 in 1 JAR
2 100 in 1 TUBE
3 3 in 1 TUBE
4 NDC:16781-216-04 18 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
K K110727 2011-08-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.